Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Stockjet who wrote (878)	3/31/1998 4:39:00 PM
From: Barron Von Hymen	Read Replies (1) \| Respond to of 9523

''It was just quarterly window-dressing, which nobody can predict,'' Dwyer said. Here are the facts. Market drives up 100 points, PFE rises 1 and change. As we approach the close, oil stocks sell off, broader market selloff also, see some profit taking on the banks, some dumping of recent winners in biotech, yet Pfizer ticks up another half. It's clear what's happening here. I think I'm looking at a $200 billion dollar company here. Think that's too high? Look at GE, $272 billion market cap. Not at all unthinkable. But I really worry about you call buyers, in the short term, market makers can manipulate the price squeezing you flat on expiration, so don't get too carried away. But if PFE continues it's momentum, it might be possible to see a short squeeze inflicted on the call writers.